Sanofi-aventis India Launches SITE

Aventis Pharma has announced the launch of SITE (Screening India’s Twin Epidemic), a cross-sectional study that aims to estimate the prevalence of diagnosed and undiagnosed cases of diabetes and hypertension in outpatient settings in major cities across India.

The study will involve 1000 general practitioners including consultant physicians and over 20,000 patients from 10 States namely – Maharashtra, New Delhi, West Bengal, Tamil Nadu, Andhra Pradesh, Karnataka, Gujarat, Uttar Pradesh, Rajasthan and Madhya Pradesh.

The study was commissioned by Sanofi-aventis with the aim of quantifying and increasing awareness amongst medical professionals and patients on the lurking likelihood of a twin epidemic of diabetes and hypertension.

The study will screen 20,000 patients, covering a wide variety of people, including businessmen, working professionals and housewives, mainly in metro cities, aged 18 years and above. The study is expected to be concluded with collated results from all 10 states by December 2010.